In October 2010, the Academy's FORUM held a roundtable focusing on research and development of medical products and the importance of regulatory science to the healthcare portfolio.Launched
Research and development of medical products: opportunities and challenges
In October 2010, the Academy's FORUM held a roundtable on 'Research and development of medical products: opportunities and challenges'.
The meeting brought together representatives from the pharmaceutical industry, medical research charities, academia and international regulatory bodies, including Dr Margaret Hamburg, Commissioner of Food and Drugs at the US Food and Drug Administration (FDA). The purpose was to explore the current and future regulatory challenges facing the pharmaceutical industry, academia and regulators, and to discuss the opportunities for overcoming these challenges to ensure that new innovations benefit patients and that regulators have access to the most effective decision-making tools. The report of the roundtable is now available.
The roundtable was followed by the Academy's annual FORUM lecture, which was delivered by Dr Hamburg on the topic of, 'The importance of regulatory science to the healthcare portfolio'.